Splicing machinery dysregulation and its relationship with PDAC aggressiveness
Eduardo Pérez(Instituto Maimónides de Investigación Biomédica de Córdoba), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Andrea Mafficini(University of Verona), Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Álvaro Arjona‐Sánchez(Instituto Maimónides de Investigación Biomédica de Córdoba), Juan Antonio Marín-Sanz(Instituto Maimónides de Investigación Biomédica de Córdoba), Cristina Viyuela-García(Instituto Maimónides de Investigación Biomédica de Córdoba), Juan M. Jiménez‐Vacas(Instituto de Salud Carlos III), M.E. Sánchez-Fría(Instituto Maimónides de Investigación Biomédica de Córdoba), Sebastián Ventura(University of Córdoba), A L Scarpa, Rita T. Lawlor(University of Verona), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Inmaculada Berbel(Instituto Maimónides de Investigación Biomédica de Córdoba), Claudio Luchini(University of Verona), Juan Manuel Sánchez‐Hidalgo(Instituto Maimónides de Investigación Biomédica de Córdoba), Ricardo Blázquez‐Encinas(Instituto Maimónides de Investigación Biomédica de Córdoba), Raúl M. Luque(Instituto de Salud Carlos III), T. Moreno Montilla(Instituto Maimónides de Investigación Biomédica de Córdoba), Antonio Pea(University of Verona)
Cited by 0
Related Papers
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach
|Annals of Oncology|2019|1k
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390